Advancing aHUS Understanding: The ISN’s International Forum in Prague Sets the Stage for Progress
The ISN’s aHUS International Forum took place from December 8-10 in Prague, the Czech Republic. The forum brought together over 80 experts in atypical hemolytic uremic syndrome (aHUS) from around the globe.
Participants at the ISN aHUS International Forum
Topics covered included terminology, evaluation, treatment of native disease, Factor H antibody and treatment, transplant, and non-complement genetic causes.
Raising awareness of aHUS in kidney care is crucial given its rarity, distinctive pathophysiology, potential for recurrence, impact on multiple organs, and the advent of targeted therapies. Raising awareness can improve early diagnosis and patient outcomes and create a better support network for those living with this challenging condition.
Faculty at the ISN aHUS International Forum
The ISN’s aHUS International Forum was supported by Alexion, AstraZeneca Rare Disease.
